Changes of urinary immunity and microbiome after intravesical BCG therapy and their association with outcomes in NMIBC

Aim: Intravesical Bacillus Calmette–Guérin (BCG) is the standard therapy for non-muscle invasive bladder cancer (NMIBC); however, many patients experience recurrence or progression. We examined how urinary immune signals and the urinary microbiome change across BCG and are related to outcomes. Metho...

תיאור מלא

מידע ביבליוגרפי

Principais autores:	Yuki Oda, Makito Miyake, Nobutaka Nishimura, Takuto Shimizu, Takuya Owari, Kota Iida, Yasushi Nakai, Nobumichi Tanaka, Kiyohide Fujimoto
פורמט:	Artigo
שפה:	Inglês
יצא לאור:	Open Exploration Publishing Inc. 2026-04-01
סדרה:	Exploration of Targeted Anti-tumor Therapy
נושאים:	bacillus calmette–guérin (bcg) therapy non-muscle invasive bladder cancer urinary immune profiling urinary microbiome dynamics firmicutes/bacteroidetes ratio progression-free survival
גישה מקוונת:	https://www.explorationpub.com/uploads/Article/A1002365/1002365.pdf
תגים:	הוספת תג אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!